Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Medicines · US (FDA)
Opioids

FDA 2007

Opioid anesthetics

Fentanyl-25

Approved 20 Aug 2007TransdermalFilm, extended release

The FDA lists this product in 9 strengths and forms.

Official labelAsk Osler about it

On this page

Composition
Strengths and forms
Official product information

The table holds no label text for this product yet, only the facts beside it. The official product information has the full text.

Composition

Active ingredients: FENTANYL 25MCG/HR

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

FENTANYL 25MCG/HR · Film, extended releaseANDA077051-001 · Discontinued
FENTANYL 25MCG/HR · Film, extended releaseThis page
FENTANYL 25MCG/HR · Film, extended releaseANDA077154-001 · Prescription
FENTANYL 25MCG/HR · Film, extended releaseANDA077449-001 · Prescription
FENTANYL 25MCG/HR · Film, extended releaseANDA076709-001 · Discontinued
FENTANYL 25MCG/HR · Film, extended releaseANDA077775-001 · Discontinued
FENTANYL 25MCG/HR · Film, extended releaseANDA076258-001 · Prescription
FENTANYL 25MCG/HR · Film, extended releaseANDA209655-002 · Discontinued
FENTANYL 25MCG/HR · Film, extended releaseANDA202097-002 · Prescription

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA077062.

More in opioids

Naloxone HydrochlorideSpray
Lofexidine HydrochlorideTablet

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Fentanyl-25
Active substance: fentanyl
Drug class: Opioid anesthetics, Phenylpiperidine derivatives
Group: Opioids
Route: Transdermal
Dosage form: Film, extended release
Applicant: Mayne Pharma
Status: Discontinued
FDA approval: 20 Aug 2007
Application: ANDA077062-001
RxCUI: 4337

FDA 2023

NaltrexoneFor suspension, extended release

FDA 2023Brixadibuprenorphine · Solution, extended release

FDA 2023Acetaminophen and Ibuprofenacetaminophen · Tablet

FDA 2023Fentanyl CitrateSolution

FDA 2021Kloxxadonaloxone hydrochloride · Spray

FDA 2019AlvimopanCapsule

FDA 2018BuprenorphineFilm, extended release

FDA 2018Buprenorphine Hydrochloride and Naloxone Hydrochloridebuprenorphine hydrochloride · Film

FDA 2018Lucemyralofexidine hydrochloride · Tablet

FDA 2018Remifentanil HydrochlorideInjectable

FDA 2017Ibuprofen and Pseudoephedrine Hydrochlorideibuprofen · Capsule

FDA 2017Sublocadebuprenorphine · Solution, extended release

FDA 2017Buprenorphine Hydrochloride; Naloxone Hydrochloridebuprenorphine hydrochloride · Film

FDA 2017Tapentadol HydrochlorideTablet

FDA 2017Vantrela ERhydrocodone bitartrate · Tablet, extended release

FDA 2016Probuphinebuprenorphine hydrochloride · Implant